Thrivent Financial for Lutherans Has $468,000 Stake in Phibro Animal Health Co. (NASDAQ:PAHC)

Thrivent Financial for Lutherans boosted its stake in Phibro Animal Health Co. (NASDAQ:PAHC) by 23.1% in the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 20,791 shares of the company’s stock after purchasing an additional 3,907 shares during the period. Thrivent Financial for Lutherans owned about 0.05% of Phibro Animal Health worth $468,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also bought and sold shares of the company. CWM LLC grew its holdings in Phibro Animal Health by 89.8% during the 2nd quarter. CWM LLC now owns 2,188 shares of the company’s stock worth $37,000 after acquiring an additional 1,035 shares during the period. nVerses Capital LLC acquired a new stake in Phibro Animal Health during the 3rd quarter worth about $70,000. Summit Securities Group LLC acquired a new stake in Phibro Animal Health during the 2nd quarter worth about $83,000. China Universal Asset Management Co. Ltd. grew its holdings in Phibro Animal Health by 63.7% during the 3rd quarter. China Universal Asset Management Co. Ltd. now owns 3,912 shares of the company’s stock worth $88,000 after acquiring an additional 1,522 shares during the period. Finally, Algert Global LLC acquired a new stake in Phibro Animal Health during the 2nd quarter worth about $193,000. 99.34% of the stock is currently owned by institutional investors and hedge funds.

Phibro Animal Health Stock Down 3.0 %

PAHC opened at $22.92 on Friday. The company has a fifty day moving average price of $23.42 and a 200-day moving average price of $20.34. The firm has a market capitalization of $928.26 million, a P/E ratio of 53.30, a price-to-earnings-growth ratio of 0.60 and a beta of 0.51. The company has a debt-to-equity ratio of 1.81, a current ratio of 3.23 and a quick ratio of 1.69. Phibro Animal Health Co. has a one year low of $10.03 and a one year high of $25.98.

Phibro Animal Health Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, December 18th. Shareholders of record on Wednesday, November 27th will be paid a $0.12 dividend. This represents a $0.48 annualized dividend and a yield of 2.09%. The ex-dividend date of this dividend is Wednesday, November 27th. Phibro Animal Health’s dividend payout ratio is presently 111.63%.

Wall Street Analyst Weigh In

Several brokerages have recently commented on PAHC. StockNews.com upgraded Phibro Animal Health from a “buy” rating to a “strong-buy” rating in a research note on Thursday, November 28th. JPMorgan Chase & Co. began coverage on Phibro Animal Health in a research note on Tuesday, September 10th. They issued a “neutral” rating and a $22.00 target price for the company. Bank of America raised their target price on Phibro Animal Health from $13.00 to $15.00 and gave the company an “underperform” rating in a research note on Friday, August 30th. Finally, Barclays raised their target price on Phibro Animal Health from $13.00 to $20.00 and gave the company an “underweight” rating in a research note on Tuesday, November 12th. Three equities research analysts have rated the stock with a sell rating, one has issued a hold rating and one has issued a strong buy rating to the company’s stock. According to data from MarketBeat.com, the company has an average rating of “Hold” and an average target price of $16.50.

Phibro Animal Health Company Profile

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.